Showing results (71-80 of 270) with videos related to
Sort By:
Pageof 27
Blood|June 29, 2012
How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatmentWaleed Ghanima, Bertrand Godeau, Douglas B Cines, et al.Medical Hypotheses|September 17, 2017
Measuring salivary blood: A potential in vivo assay to quantify platelet transfusion efficacyThomas J Gniadek, Shelley Pulkrabek, Claudia S CohnTransfusion|February 4, 2015
The use of autologous platelet-rich plasma in the orthopedic settingClaudia S Cohn, Evelyn Lockhart, J Jeffrey McCulloughAmerican Journal of Perinatology|November 10, 2006
Long-term effects of fetal and neonatal alloimmune thrombocytopenia and its antenatal treatment on the medical and developmental outcomes of affected childrenMary J Ward, Joanne Pauliny, Evelyn G Lipper, et al.Blood|August 19, 2007
Multiagent induction and maintenance therapy for patients with refractory immune thrombocytopenic purpura (ITP)Donna M Boruchov, Sri Gururangan, M Catherine Driscoll, et al.Haematologica|May 11, 2019
Thrombopoietin receptor agonists: ten years laterWaleed Ghanima, Nichola Cooper, Francesco Rodeghiero, et al.Haematologica|April 2, 2014
Primary thrombocytosis in childrenNicole Kucine, Katherine M Chastain, Michelle B Mahler, et al.American Journal of Hematology|December 22, 2005
Efficacy of mycophenolate mofetil as single-agent therapy for refractory immune thrombocytopenic purpuraDrew Provan, Ashley J Moss, Adrian C Newland, et al.British Journal of Haematology|November 21, 2009
Complement activation on platelets correlates with a decrease in circulating immature platelets in patients with immune thrombocytopenic purpuraEllinor I B Peerschke, Biree Andemariam, Wei Yin, et al.British Journal of Haematology|December 12, 2023
The highs and lows of cyclic thrombocytopeniaHaiyu Zhang, Alejandro Villar-Prados, James B Bussel, et al.Pageof 27